Role of SAP102 in mutant Huntingtin-mediated regulation of NMDA receptor function in the YAC transgenic mouse model of Huntington Disease

Huntington disease (HD) is a dominantly inherited neurodegenerative disease, which is caused by polyglutamine (polyQ) expansion in the protein huntingtin (htt). Increasing evidence suggests that the N-methyl-D-aspartate (NMDA)-type glutamate receptor plays a role in mediating death of striatal me...

Full description

Bibliographic Details
Main Author: Fan, Jing
Language:English
Published: University of British Columbia 2011
Online Access:http://hdl.handle.net/2429/31685
id ndltd-UBC-oai-circle.library.ubc.ca-2429-31685
record_format oai_dc
spelling ndltd-UBC-oai-circle.library.ubc.ca-2429-316852018-01-05T17:46:13Z Role of SAP102 in mutant Huntingtin-mediated regulation of NMDA receptor function in the YAC transgenic mouse model of Huntington Disease Fan, Jing Huntington disease (HD) is a dominantly inherited neurodegenerative disease, which is caused by polyglutamine (polyQ) expansion in the protein huntingtin (htt). Increasing evidence suggests that the N-methyl-D-aspartate (NMDA)-type glutamate receptor plays a role in mediating death of striatal medium-sized spiny neurons (MSNs) observed in HD. For example, previous results from our laboratory demonstrate that NMDA receptor (NMDAR)-mediated current and toxicity is increased in neurons from the Yeast Artificial Chromosome (YAC) transgenic mouse model expressing huntingtin with 72 polyQ (YAC72), and suggest that an increase in surface NMDAR number is the trigger for increased cytosolic calcium, ultimately resulting in activation of caspases and leading to neuronal death. Here, I hypothesize that potentiation of NMDAR surface expression and excitotoxicity by mutant htt (mhtt) may be mediated in part by interaction with membrane-associated guanylate kinases (MAGUKs) such as PSD-95 or SAP102. I report the novel finding that htt is co-immunoprecipitated with SAP102 in HEK293T cells and in striatal tissue from wild-type and YAC transgenic mice, but that the association of SAP102 with the NMDAR NR2B subunit or htt is not altered by htt polyQ length. However, by using a Tat-NR2B9c peptide to block binding between NR2B and either SAP 102 or PSD-95 in cultured striatal neurons, I show that this interaction plays a key role in mediating the increase in NMDAR surface expression and NMDA-induced toxicity observed with mhtt expression. Moreover, the Tat-NR2B9c peptide has no effect on glutamate receptor 1 (GluRl) surface expression or staurosporine-induced toxicity. The mechanism by which SAP 102 and/or PSD-95 mediates the altered NMDAR trafficking and function observed with mhtt expression remains to be explored. My research may help to elucidate further the mechanisms underlying enhanced excitotoxicity in HD. Medicine, Faculty of Graduate 2011-02-23T20:19:02Z 2011-02-23T20:19:02Z 2007 Text Thesis/Dissertation http://hdl.handle.net/2429/31685 eng For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use. University of British Columbia
collection NDLTD
language English
sources NDLTD
description Huntington disease (HD) is a dominantly inherited neurodegenerative disease, which is caused by polyglutamine (polyQ) expansion in the protein huntingtin (htt). Increasing evidence suggests that the N-methyl-D-aspartate (NMDA)-type glutamate receptor plays a role in mediating death of striatal medium-sized spiny neurons (MSNs) observed in HD. For example, previous results from our laboratory demonstrate that NMDA receptor (NMDAR)-mediated current and toxicity is increased in neurons from the Yeast Artificial Chromosome (YAC) transgenic mouse model expressing huntingtin with 72 polyQ (YAC72), and suggest that an increase in surface NMDAR number is the trigger for increased cytosolic calcium, ultimately resulting in activation of caspases and leading to neuronal death. Here, I hypothesize that potentiation of NMDAR surface expression and excitotoxicity by mutant htt (mhtt) may be mediated in part by interaction with membrane-associated guanylate kinases (MAGUKs) such as PSD-95 or SAP102. I report the novel finding that htt is co-immunoprecipitated with SAP102 in HEK293T cells and in striatal tissue from wild-type and YAC transgenic mice, but that the association of SAP102 with the NMDAR NR2B subunit or htt is not altered by htt polyQ length. However, by using a Tat-NR2B9c peptide to block binding between NR2B and either SAP 102 or PSD-95 in cultured striatal neurons, I show that this interaction plays a key role in mediating the increase in NMDAR surface expression and NMDA-induced toxicity observed with mhtt expression. Moreover, the Tat-NR2B9c peptide has no effect on glutamate receptor 1 (GluRl) surface expression or staurosporine-induced toxicity. The mechanism by which SAP 102 and/or PSD-95 mediates the altered NMDAR trafficking and function observed with mhtt expression remains to be explored. My research may help to elucidate further the mechanisms underlying enhanced excitotoxicity in HD. === Medicine, Faculty of === Graduate
author Fan, Jing
spellingShingle Fan, Jing
Role of SAP102 in mutant Huntingtin-mediated regulation of NMDA receptor function in the YAC transgenic mouse model of Huntington Disease
author_facet Fan, Jing
author_sort Fan, Jing
title Role of SAP102 in mutant Huntingtin-mediated regulation of NMDA receptor function in the YAC transgenic mouse model of Huntington Disease
title_short Role of SAP102 in mutant Huntingtin-mediated regulation of NMDA receptor function in the YAC transgenic mouse model of Huntington Disease
title_full Role of SAP102 in mutant Huntingtin-mediated regulation of NMDA receptor function in the YAC transgenic mouse model of Huntington Disease
title_fullStr Role of SAP102 in mutant Huntingtin-mediated regulation of NMDA receptor function in the YAC transgenic mouse model of Huntington Disease
title_full_unstemmed Role of SAP102 in mutant Huntingtin-mediated regulation of NMDA receptor function in the YAC transgenic mouse model of Huntington Disease
title_sort role of sap102 in mutant huntingtin-mediated regulation of nmda receptor function in the yac transgenic mouse model of huntington disease
publisher University of British Columbia
publishDate 2011
url http://hdl.handle.net/2429/31685
work_keys_str_mv AT fanjing roleofsap102inmutanthuntingtinmediatedregulationofnmdareceptorfunctionintheyactransgenicmousemodelofhuntingtondisease
_version_ 1718594512356376576